There is an urgent need for investment in long Covid clinical trials, and in decentralized clinical trials like this one in particular, says Hannah Davis, cofounder of the Patient-Led Research Collaborative, a long Covid research and advocacy group
How is combined or alternating use of GLOW and KLOW evaluated
M281: a therapeutic FcRn blocking antibody for rapid clearance of IgG and IgG
EBioMedicine 40 , 6776 (2019)
Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, Lau ESH, Eliasson B, Kong APS, Ezzati M, Aguilar-Salinas CA, McGill M, Levitt NS, Ning G, So WY, Adams J, Bracco P, Forouhi NG, Gregory GA, Guo J, Hua X, Klatman EL, Magliano DJ, Ng BP, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma RCW, Schmidt MI, Ramachandran A, Seino Y, Bennett PH, Oldenburg B, Gagliardino JJ, Luk AOY, Clarke PM, Ogle GD, Davies MJ, Holman RR, Gregg EW